Chargement en cours...

α6β2* and α4β2* Nicotinic Acetylcholine Receptors As Drug Targets for Parkinson's Disease

Parkinson's disease is a debilitating movement disorder characterized by a generalized dysfunction of the nervous system, with a particularly prominent decline in the nigrostriatal dopaminergic pathway. Although there is currently no cure, drugs targeting the dopaminergic system provide major s...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Quik, Maryka, Wonnacott, Susan
Format: Artigo
Langue:Inglês
Publié: The American Society for Pharmacology and Experimental Therapeutics 2011
Sujets:
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC3186078/
https://ncbi.nlm.nih.gov/pubmed/21969327
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1124/pr.110.003269
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!